^
BIOMARKER:

KMT2A rearrangement

i
Other names: KMT2A, Lysine Methyltransferase 2A, Histone-Lysine N-Methyltransferase 2A, CXXC7, TRX1, Myeloid/Lymphoid Or Mixed-Lineage Leukemia (Trithorax Homolog, Drosophila), Lysine (K)-Specific Methyltransferase 2A, CXXC-Type Zinc Finger Protein 7, Lysine N-Methyltransferase 2A, Zinc Finger Protein HRX, Trithorax-Like Protein, HTRX1, MLL1A, MLL1, MLL, Myeloid/Lymphoid Or Mixed-Lineage Leukemia (Trithorax (Drosophila) Homolog), Myeloid/Lymphoid Or Mixed-Lineage Leukemia Protein 1, Myeloid/Lymphoid Or Mixed
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
KMT2A rearrangement
Acute Lymphocytic Leukemia
CEP-701
Sensitive
:
B
KMT2A rearrangement
Acute Myelogenous Leukemia
gemtuzumab ozogamicin
Sensitive
:
C3
KMT2A rearrangement
Childhood B Acute Lymphoblastic Leukemia
blinatumomab
Sensitive
:
C3
KMT2A rearrangement
Acute Lymphocytic Leukemia
azacitidine
Sensitive
:
C4
KMT2A rearrangement
Childhood B Acute Lymphoblastic Leukemia
DS-M1
Sensitive
:
D
KMT2A rearrangement
Acute Lymphocytic Leukemia
FLT3 inhibitor + gilteritinib
Sensitive
:
D
KMT2A rearrangement
Acute Lymphocytic Leukemia
Menin-MLL inhibitor
Sensitive
:
D